Vanguard Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-3,640,151
Closed -$1.19B – 4470
2024
Q1
$1.19B Buy
3,640,151
+6,431
+0.2% +$1.58M 0.02% 593
2023
Q4
$692M Buy
3,633,720
+33,539
+0.9% +$6.34M 0.02% 792
2023
Q3
$717M Sell
3,600,181
-2,833
-0.1% -$670K 0.02% 721
2023
Q2
$1.03B Sell
3,603,014
-137,387
-4% -$38.2M 0.02% 599
2023
Q1
$811M Buy
3,740,401
+45,470
+1% +$8.86M 0.02% 662
2022
Q4
$760M Buy
3,694,931
+163,646
+5% +$41.4M 0.02% 676
2022
Q3
$982M Buy
3,531,285
+13,619
+0.4% +$3.46M 0.03% 569
2022
Q2
$672M Buy
3,517,666
+206,109
+6% +$36.4M 0.02% 703
2022
Q1
$687M Buy
3,311,557
+67,789
+2% +$11.2M 0.02% 784
2021
Q4
$578M Buy
3,243,768
+51,602
+2% +$10.2M 0.01% 909
2021
Q3
$657M Buy
3,192,166
+216,384
+7% +$42.5M 0.02% 816
2021
Q2
$565M Buy
2,975,782
+86,004
+3% +$14.1M 0.01% 918
2021
Q1
$376M Buy
2,889,778
+96,889
+3% +$11.6M 0.01% 1139
2020
Q4
$290M Buy
2,792,889
+563,951
+25% +$48.8M 0.01% 1223
2020
Q3
$169M Buy
2,228,938
+225,970
+11% +$12.8M 0.01% 1378
2020
Q2
$94.9M Buy
2,002,968
+267,559
+15% +$11M ﹤0.01% 1704
2020
Q1
$57.6M Buy
1,735,409
+30,277
+2% +$1.2M ﹤0.01% 1804
2019
Q4
$74.9M Buy
1,705,132
+994,688
+140% +$36.7M ﹤0.01% 1909
2019
Q3
$21.3M Buy
710,444
+44,348
+7% +$1.88M ﹤0.01% 2467
2019
Q2
$38M Buy
666,096
+616,096
+1,232% +$29.9M ﹤0.01% 2241
2019
Q1
$1.67M Buy
+50,000
New +$1.66M ﹤0.01% 3506

Other funds holding SWAV

Vanguard Group's SWAV Position: Q2 2024 in Review

Vanguard Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 3,640,151 shares — an estimated $1.19B sold.

Vanguard Group first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $1.19B in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Vanguard Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Vanguard Group sold 3,640,151 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.19B.
  • Vanguard Group first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 21 quarters.
  • Vanguard Group's Shockwave Medical, Inc. Common Stock position peaked at $1.19B in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Vanguard Group's 13F filing for Q2 2024, filed 13 Aug 2024.